Patents by Inventor Teresa Lama

Teresa Lama has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Beta-turn peptidomimetic cyclic compounds for treating dry eye
    Patent number: 9707267
    Abstract: The present invention relates to methods of treating dry eye using ?-turn peptidomimetic cyclic compounds or derivatives thereof. The ?-turn peptidomimetic cyclic compounds can be used alone, in combination and/or in conjunction with one or more other compounds, molecules or drugs that treat dry eye.
    Type: Grant
    Filed: September 18, 2015
    Date of Patent: July 18, 2017
    Assignee: Mimetogen Pharmaceuticals, Inc.
    Inventors: Garth Cumberlidge, Karen Meerovitch, Teresa Lama, Horacio Uri Saragovi
  • BETA-TURN PEPTIDOMIMETIC CYCLIC COMPOUNDS FOR TREATING DRY EYE
    Publication number: 20160082072
    Abstract: The present invention relates to methods of treating dry eye using ?-turn peptidomimetic cyclic compounds or derivatives thereof. The ?-turn peptidomimetic cyclic compounds can be used alone, in combination and/or in conjunction with one or more other compounds, molecules or drugs that treat dry eye.
    Type: Application
    Filed: September 18, 2015
    Publication date: March 24, 2016
    Inventors: Garth CUMBERLIDGE, Karen MEEROVITCH, Teresa LAMA
  • Beta-turn peptidomimetic cyclic compounds for treating dry eye
    Patent number: 9156882
    Abstract: The present invention relates to methods of treating dry eye using ?-turn peptidomimetic cyclic compounds or derivatives thereof. The ?-turn peptidomimetic cyclic compounds can be used alone, in combination and/or in conjunction with one or more other compounds, molecules or drugs that treat dry eye.
    Type: Grant
    Filed: May 29, 2014
    Date of Patent: October 13, 2015
    Assignee: MIMETOGEN PHARMACEUTICALS, INC.
    Inventors: Garth Cumberlidge, Karen Meerovitch, Teresa Lama
  • Synthesis of beta-turn peptidomimetic cyclic compounds
    Patent number: 9115179
    Abstract: The present invention relates to methods of preparing ?-turn cyclic peptidomimetic compounds and intermediates thereof. Particularly, the present invention relates to a process for the synthesis of ?-turn cyclic peptidomimetic compounds of formula I: where R1, R2, R3, R4, R5, R6, R7, L2, X, Y and n are as defined in the specification. The present invention provides a more efficient route for preparing ?-turn cyclic peptidomimetic compounds and intermediates thereof.
    Type: Grant
    Filed: June 7, 2013
    Date of Patent: August 25, 2015
    Assignee: Mimetogen Pharmaceuticals Inc.
    Inventors: Teresa Lama, Jeanick Pascal
  • BETA-TURN PEPTIDOMIMETIC CYCLIC COMPOUNDS FOR TREATING DRY EYE
    Publication number: 20140274910
    Abstract: The present invention relates to methods of treating dry eye using ?-turn peptidomimetic cyclic compounds or derivatives thereof. The ?-turn peptidomimetic cyclic compounds can be used alone, in combination and/or in conjunction with one or more other compounds, molecules or drugs that treat dry eye.
    Type: Application
    Filed: May 29, 2014
    Publication date: September 18, 2014
    Applicant: Mimetogen Pharmaceuticals, Inc.
    Inventors: Garth CUMBERLIDGE, Karen MEEROVITCH, Teresa LAMA
  • ?-turn peptidomimetic cyclic compounds for treating dry eye
    Patent number: 8748391
    Abstract: The present invention relates to methods of treating dry eye using ?-turn peptidomimetic cyclic compounds or derivatives thereof. The ?-turn peptidomimetic cyclic compounds can be used alone, in combination and/or in conjunction with one or more other compounds, molecules or drugs that treat dry eye.
    Type: Grant
    Filed: August 31, 2012
    Date of Patent: June 10, 2014
    Assignee: Mimetogen Pharmaceuticals Inc.
    Inventors: Garth Cumberlidge, Karen Meerovitch, Teresa Lama
  • SYNTHESIS OF BETA-TURN PEPTIDOMIMETIC CYCLIC COMPOUNDS
    Publication number: 20130345395
    Abstract: The present invention relates to methods of preparing ?-turn cyclic peptidomimetic compounds and intermediates thereof. Particularly, the present invention relates to a process for the synthesis of ?-turn cyclic peptidomimetic compounds of formula I: where R1, R2, R3, R4, R5, R6, R7, L2, X, Y and n are as defined in the specification. The present invention provides a more efficient route for preparing ?-turn cyclic peptidomimetic compounds and intermediates thereof.
    Type: Application
    Filed: June 7, 2013
    Publication date: December 26, 2013
    Inventors: Teresa Lama, Jeanick Pascal
  • BETA-TURN PEPTIDOMIMETIC CYCLIC COMPOUNDS FOR TREATING DRY EYE
    Publication number: 20120322747
    Abstract: The present invention relates to methods of treating dry eye using ?-turn peptidomimetic cyclic compounds or derivatives thereof. The ?-turn peptidomimetic cyclic compounds can be used alone, in combination and/or in conjunction with one or more other compounds, molecules or drugs that treat dry eye.
    Type: Application
    Filed: August 31, 2012
    Publication date: December 20, 2012
    Applicant: Mimetogen Pharmaceuticals USA, Inc.
    Inventors: GARTH CUMBERLIDGE, Karen Meerovitch, Teresa Lama
  • Beta-turn peptidomimetic cyclic compounds for treating dry eye
    Patent number: 8293713
    Abstract: The present invention relates to methods of treating dry eye using ?-turn peptidomimetic cyclic compounds or derivatives thereof. The ?-turn peptidomimetic cyclic compounds can be used alone, in combination and/or in conjunction with one or more other compounds, molecules or drugs that treat dry eye.
    Type: Grant
    Filed: April 3, 2009
    Date of Patent: October 23, 2012
    Assignee: Mimetogen Pharmaceuticals, Inc.
    Inventors: Garth Cumberlidge, Karen Meerovitch, Teresa Lama
  • Beta-Turn Peptidomimetic Cyclic Compounds for Treating Dry Eye
    Publication number: 20110105410
    Abstract: The present invention relates to methods of treating dry eye using ?-turn peptidomimetic cyclic compounds or derivatives thereof. The ?-turn peptidomimetic cyclic compounds can be used alone, in combination and/or in conjunction with one or more other compounds, molecules or drugs that treat dry eye.
    Type: Application
    Filed: April 3, 2009
    Publication date: May 5, 2011
    Inventors: Garth Cumberlidge, Karen Meerovitch, Teresa Lama